Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma

被引:0
作者
Pahlman, L
Glimelius, B
Cedermark, B
Lundell, G
Rieger, A
Rutquist, LE
Theve, T
Wilking, N
Bengtsson, NO
Blomgren, H
Rubio, C
Ost, A
Brismar, B
Wikstrom, B
Ewerth, S
Dahlgren, S
Forsgren, L
Friberg, S
Johansson, C
Magnusson, I
Sundelin, P
Svensson, C
Tornberg, B
Fenyo, G
Ljungdahl, I
Svensson, SO
Molin, K
Goldman, S
Lasarett, V
Bark, S
Robertsson, B
Dalen, J
Raf, L
Ohman, U
Nilsson, SE
Westman, M
Liljeholm, H
Bendzen, O
Ljunquist, U
Nihlberg, A
Heuman, R
Lorentz, T
BisgaardPedersen, A
Bergstrom, S
Krog, M
Tuvesson, T
Edman, P
Lindstrom, C
Sandhammar, B
Tyden, G
机构
关键词
rectum; tumour; radiotherapy; local recurrence;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To find out whether short-term high-dose preoperative radiotherapy can reduce local recurrence rate without increasing postoperative mortality in patients with resectable rectal cancer. Design: Randomised trial. Setting: Nationwide Swedish multicentre trial. Subjects: From March 1987 to February 1990, 1168 patients were randomised. In each group, 454 patients had curative surgery. Interventions: Patients were allocated to preoperative irradiation (25 Gy in five fractions in one week) followed by operation within a week, or to surgery alone. Main outcome measures: Postoperative morbidity and mortality, and local recurrence rate. Results: After a minimum follow-up of two years, 9% (51/553) of the patients in the irradiated group who had had the tumour resected had developed a local recurrence, compared with 24% (131/557) in the surgery alone group (p < 0.001). In patients who underwent curative operations, the local recurrence rates were 7% (33/454) and 20% (93/454), respectively (p < 0.001). The corresponding figures for all patients with Dukes' stage tumours were: A 3% (6/181) and 9% (14/154) (p = 0.04); Dukes' stage B 7% (14/195) and 18% (31/173), (p < 0.01) and Dukes' stage C 18% (31/177) and 37% (86/230), (p < 0.001), respectively. Conclusion: Preoperative irradiation with a short-term high-dose regimen reduces the local recurrence rate by roughly 65% after a minimum follow-up of two years. The influence on survival will be analysed after a minimum of five years follow-up.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 24 条
[21]   Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial [J].
Hong, Yong Sang ;
Nam, Byung-Ho ;
Kim, Kyu-pyo ;
Kim, Jeong Eun ;
Park, Seong Joon ;
Park, Young Suk ;
Park, Joon Oh ;
Kim, Sun Young ;
Kim, Tae-You ;
Kim, Jee Hyun ;
Ahn, Joong Bae ;
Lim, Seok-Byung ;
Yu, Chang Sik ;
Kim, Jin Cheon ;
Yun, Seong Hyeon ;
Kim, Jong Hoon ;
Park, Jin-hong ;
Park, Hee Chul ;
Jung, Kyung Hae ;
Kim, Tae Won .
LANCET ONCOLOGY, 2014, 15 (11) :1245-1253
[22]   Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial [J].
Roedel, Claus ;
Liersch, Torsten ;
Becker, Heinz ;
Fietkau, Rainer ;
Hohenberger, Werner ;
Hothorn, Torsten ;
Graeven, Ullrich ;
Arnold, Dirk ;
Lang-Welzenbach, Marga ;
Raab, Hans-Rudolf ;
Suelberg, Heiko ;
Wittekind, Christian ;
Potapov, Sergej ;
Staib, Ludger ;
Hess, Clemens ;
Weigang-Koehler, Karin ;
Grabenbauer, Gerhard G. ;
Hoffmanns, Hans ;
Lindemann, Fritz ;
Schlenska-Lange, Anke ;
Folprecht, Gunnar ;
Sauer, Rolf ;
Lahmer, G. ;
Golcher, H. ;
Klautke, G. ;
Hartmann, A. ;
Rau, T. ;
Keilholz, L. ;
Henneking, K. ;
Muehldorfer, S. ;
Klein, S. ;
Stolte, M. ;
Staar, S. ;
Lehnert, T. ;
Hertenstein, B. ;
Freys, S. M. ;
Pflueger, K.-H. ;
Sendt, W. ;
Teyssen, S. ;
Latz, D. ;
Leibl, B. J. ;
Matek, W. ;
Grabenbauer, G. G. ;
Alfrink, M. ;
Kreczy, A. ;
Strobel, G. F. ;
Duewel, H.-J. ;
Bechstein, W. O. ;
Gog, C. ;
Boettcher, H.-D. .
LANCET ONCOLOGY, 2012, 13 (07) :679-687
[23]   Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II-III resectable rectal cancer: 5-Year survival data of a randomized controlled trial [J].
Kairevice, Laura ;
Latkauskas, Tadas ;
Tamelis, Algimantas ;
Petrauskas, Aleksandras ;
Pauzas, Henrikas ;
Zvirblis, Tadas ;
Jarusevicius, Laimonas ;
Saladzinskas, Zilvinas ;
Pavalkis, Dainius ;
Janciauskiene, Rasa .
MEDICINA-LITHUANIA, 2017, 53 (03) :150-158
[24]   Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial [J].
Roedel, Claus ;
Graeven, Ullrich ;
Fietkau, Rainer ;
Hohenberger, Werner ;
Hothorn, Torsten ;
Arnold, Dirk ;
Hofheinz, Ralf-Dieter ;
Ghadimi, Michael ;
Wolff, Hendrik A. ;
Lang-Welzenbach, Marga ;
Raab, Hans-Rudolf ;
Wittekind, Christian ;
Stroebel, Philipp ;
Staib, Ludger ;
Wilhelm, Martin ;
Grabenbauer, Gerhard G. ;
Manns, Hans Hoff ;
Lindemann, Fritz ;
Schlenska-Lange, Anke ;
Folprecht, Gunnar ;
Sauer, Rolf ;
Liersch, Torsten ;
Sauer, R. ;
Hohenberger, W. ;
Fietkau, R. ;
Lahmer, G. ;
Golcher, H. ;
Klautke, G. ;
Hartmann, A. ;
Rau, T. ;
Keilholz, L. ;
Henneking, K. ;
Muehldorfer, S. ;
Klein, S. ;
Stolte, M. ;
Staar, S. ;
Lehnert, T. ;
Hertenstein, B. ;
Freys, S. M. ;
Pflueger, K.-H. ;
Sendt, W. ;
Teyssen, S. ;
Latz, D. ;
Leibl, B. J. ;
Matek, W. ;
Grabenbauer, G. G. ;
Alfrink, M. ;
Kreczy, A. ;
Strobel, G. F. ;
Düwel, H.-J. .
LANCET ONCOLOGY, 2015, 16 (08) :979-989